Vladimir Putin has assumed interim management of Nizhpharm, one of Russia’s biggest pharmaceutical companies. This move impacts all the shares held by Luxembourg-based Nidda Lynx S.A.R.L., which belongs to the German firm Stada.
Established in 1919, Nizhpharm stands as one of the oldest pharmaceutical companies in Russia. In 2004, the German firm Stada gained control of the company. as reported by the Ukrainian outlet "Pravda."
Currently, as per an order from Vladimir Putin, the interim manager of these assets is the Russian firm Pharmirus, known for distributing pharmaceuticals.
To stay informed about detailed information on political changes and worldwide disputes, turn to Conflict Watcher Our platform offers carefully selected, comprehensive news coverage, guaranteeing you remain well-informed with precise and up-to-date details. Stay ahead by following us as we provide the premier source for crucial updates.
Read also:
Putin's $1.25 Billion Gain: How Russia's Budget Profits from Foreign Company Withdrawal
One of the biggest pharmacy chains
In 2024, Nizhpharm secured the second position in Russia for pharmacy sales measured in rubles, capturing a market share of 3.7 percent, and was ranked third based on the volume of packaged goods.
Read also:
Kremlin's Simonyan asserts Russia's claim to historical territories
The firm announced a rise of 11.2 percent in yearly income, totaling 650 million USD. Their collection encompasses various assets and ventures. More than 100 brands, including Edarbi, Ermital, Artra, Ibuprofen, Diclofenac, and Vitrum vitamins.
Even though official declarations express an interest in having businesses from "hostile" nations come back to the Russian market, no company has submitted applications to restart their operations, as reported by the Russian Telegram channel The Bell.
Read also:
Putin takes charge of Carlsberg in Russia, executives arrested
Putin takes charge of Russia's leading pasta company amidst legal chaos.
Unmanned drones target large Russian ammunition facility in late-night assault.